Evozyne, founded in 2020 by Dr. Rama Ranganathan and Dr. Andrew Ferguson, is a biotechnology company specializing in the design and engineering of novel proteins to address significant challenges in healthcare and sustainability. By leveraging principles of evolution and employing generative artificial intelligence (AI), Evozyne creates high-performance, adaptive proteins with advanced functionalities aimed at developing life-changing treatments and potentially curing previously untreatable diseases.
The company has attracted substantial investment from prominent entities, including Fidelity Management & Research Company, OrbiMed, NVentures (NVIDIA’s venture capital arm), Paragon Biosciences, and Valor Equity Partners. In September 2023, Evozyne announced the closing of an $81 million Series B investment round to advance its generative AI-powered drug discovery platform and product development.
Evozyne’s uniqueness lies in its integration of evolutionary biology with generative AI to design synthetic proteins that emulate millions of years of natural evolution. This approach enables the creation of proteins with enhanced functions, addressing longstanding therapeutic challenges and environmental issues such as carbon capture. For instance, in collaboration with NVIDIA, Evozyne developed the Protein Transformer Variational AutoEncoder (ProT-VAE), a deep learning model that learns the rules of protein function to design new proteins with improved functionalities.
In the artificial intelligence landscape, Evozyne operates within the category of generative AI for protein engineering. Its technology applies deep learning models to biological data, facilitating the design of novel proteins for therapeutic development and environmental applications.
For more information, please visit evozyne.com.
To claim this startup page, go to the Contact page and send us a message with your full name, startup name, job title, and startup email address. We will review your request and get back to you. Once verified, you can update your startup information.